Frontlight ResearchEarly access
Trial site
David Geffen School of Medicine
- 4running trials
- 2closed trials
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Acute myeloid leukaemia1 trial
- Chronic lymphocytic leukaemia1 trial
- Lung cancer1 trial
- Spinal muscular atrophy1 trial
- Phase
- Phase 1/22 trials
- Phase 22 trials
- Phase 31 trial
- Status
- Active, not recruiting3 trials
- Completed2 trials
- Not yet recruiting1 trial
- Lead sponsor
- Daiichi Sankyo2 trials
- Biogen1 trial
- Genmab1 trial
- Sanofi1 trial
- University of California, Los Angeles1 trial
Running trials
Active, not recruiting
Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 17 Nov 2026